Therapeutics: Interleukin-33 (IL-33; NF-HEV); monocyte chemoattractant protein-1 (MCP-1; CCL2)

Neurology

INDICATION: Spinal cord injury (SCI)

In vitro and mouse studies suggest IL-33 agonists or CCL2

Read the full 145 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE